Eloxx Pharmaceuticals, Inc. (ELOX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 22, 2026
Eloxx Pharmaceuticals Market Cap
Eloxx Pharmaceuticals has a market cap or net worth of $330 as of January 23, 2026. Its market cap has decreased by -99.98% in one year.
Market Cap
330.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 21, 2017, Eloxx Pharmaceuticals's market cap has decreased from 23.05M to 330.00, a decrease of -100.00%. That is a compound annual growth rate of -74.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 330.00 | - |
| Dec 31, 2025 | 330.00 | 10,900.00% |
| Dec 31, 2024 | 3.00 | -100.00% |
| Dec 29, 2023 | 3.77M | -4.33% |
| Dec 30, 2022 | 3.94M | -93.53% |
| Dec 31, 2021 | 60.91M | -61.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pathfinder Cell Therapy | 667.00 |
| U.S. Stem Cell | 662.00 |
| Amarantus BioScience Holdings | 630.00 |
| GlobeImmune | 575.00 |
| Tetra Bio-Pharma | 516.00 |
| RegeneRx Biopharmaceuticals | 453.00 |
| Nabriva Therapeutics | 323.00 |
| Predictive Technology Group | 317.00 |